Biomarkers refer to genes, molecules or certain characteristics enabling to evaluate or measure pharmacologic response to therapeutic treatment, or various pathogenic or biological processes. Categorized by their utilization in different medical procedures, biomarkers facilitate decision-taking in early clinical drug development, thus helping to detect a patient’s health state. Oncology belongs within the major diseases where biomarkers are widely used.
Supported by novel product’s introductions, fresh market entrants, as well as M&As and other related activities, the world Biomarkers Market is evolving at a colossal tempo, set to be ultimately valued at just over EUR 26 billion by end-2018. Novel technologies exploited for biomarker discovery are the foremost contributors to the Biomarkers sector. North America heads the market as the most speedily growing geographic area. Major Biomarkers Market participants encompass, among others, Abbot Laboratories, Affymetrix, Agilent, Epigenomics, Celera, GE Healthcare, and DiagnoCure.
The research reports under this MarketPublishers’ Catalogue delve deep into the Biomarkers Market and its major submarkets – discovery technologies, services market, application market, and various indications. Covering various geographies, the research reports identify and examine the principal trends, opportunities, and the factors propelling or clogging the market growth. The competitive landscape with comprehensive profiles of numerous players in the global Biomarkers Industry, forecasts throwing light on the market’s future are provided in the research reports too.
Publications found:
134
Sort by:
Predictive Biomarkers Market Size, Share and Growth Outlook 2026: By Offering Type (Consumables, Services, Software), By Class, By Technology Matrix, By Disease Indication, By Application Scope, By End-User Sector, Companies to 2034.
US$ 3,482.00
The global Predictive Biomarkers Market size is forecast to increase from $9.51 Billion in 2026 to $22.52 Billion in 2034 at a CAGR of 11.38% between 2026 and 2034. The Predictive Biomarkers market re...
July 2026
190 pages
Global Cancer Biomarker Testing Market - 2026-2033
US$ 3,400.00
Global Cancer Biomarker Testing Market reached US$ 37.58 Billion in 2025 and is expected to reach US$ 96.53 billion by 2033, growing with a CAGR of 12.60% during the forecast period 2026-2033. The Glo...
July 2026
57 pages
Blood Based Biomarkers Market - 2026-2035
US$ 3,400.00
Blood Based Biomarkers Market reached US$ 10.78 billion in 2025 and is expected to reach US$ 41.43 billion by 2035, growing with a CAGR of 14.20% during the forecast period 2026-2035. The Blood Based...
July 2026
48 pages
Biomarkers Market by Offering (Consumables, Software, Service), Type (Safety, Efficacy, Validation), Research Area (Genomics, Proteomics), Technology (PCR, NGS, MS), Disease (Cancer, CVD), Application (Diagnostic, Drug Discovery) - Global Forecast to 2031
US$ 4,950.00
... biomarkers market Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, and new product launches in the biomarkers market Market ...
July 2026
732 pages
Cell Signaling Market - 2026-2033
US$ 3,400.00
Cell Signaling Marketis is growing with a CAGR of 8.12% during the forecast period 2026-2035. The Cell Signaling Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where sea...
July 2026
40 pages
South Korea Biomarkers Market Report by Product (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2026-2034
US$ 2,999.00
South Korea biomarkers market size reached USD 1,930.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 5,637.4 Million by 2034, exhibiting a growth rate (CAGR) of 12.27%...
July 2026
121 pages
South Korea Cancer Biomarkers Market Size, Share, Trends and Forecast by Profiling Technology, Biomolecule, Cancer Type, Application, End User, and Region, 2026-2034
US$ 2,999.00
The South Korea cancer biomarkers market size reached USD 662.4 Million in 2025. The market is projected to reach USD 1,626.7 Million by 2034, exhibiting a growth rate (CAGR) of 10.18% during 2026-203...
July 2026
116 pages
Cancer Biomarkers Market Report by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics), Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, and Others), Application (Diagnostics, Prognostics, Risk Assessment, Drug Discovery and Development, and Others), End User (Hospitals, Academic and Research Institutions, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others), and Region 2026-2034
US$ 2,999.00
The global cancer biomarkers market size reached USD 34.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 91.2 Billion by 2034, exhibiting a growth rate (CAGR) of 10.97%...
June 2026
145 pages
Mexico Cancer Biomarkers Market Size, Share, Trends and Forecast by Profiling Technology, Biomolecule, Cancer Type, Application, End User, and Region, 2026-2034
US$ 2,999.00
The Mexico cancer biomarkers market size reached USD 521.7 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,287.0 Million by 2034, exhibiting a growth rate (CAGR) of 10....
June 2026
118 pages
Vocal Biomarker Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technique (Frequency, Amplitude, Error Rate, Vocal Rise or Fall Time, Phonation Time, Vocal Tremor, Pitch, Others), By Indication (Psychiatric Disorders, Respiratory Disorders, Cardiovascular Disorders, Traumatic Brain Injury (TBI), Neurological disorders, Other), By End-User (Hospitals & Clinics, Ambulatory care Centers, Others) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Vocal Biomarker Market is projected to expand significantly, from USD 2.11 Billion in 2025 to USD 3.61 Billion by 2031, demonstrating a compound annual growth rate (CAGR) of 9.36%. Vocal bi...
May 2026
180 pages
Neurological Biomarkers Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Type (Imaging, Proteomic, Genomic, Metabolomic, Others), By Application (Multiple Sclerosis, Alzheimer's Disease, Autism Spectrum Disorder, Parkinson's Disease, Others), By End-User (Research Organizations, Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Neurological Biomarkers Market is projected to expand significantly, rising from USD 8.81 Billion in 2025 to USD 14.12 Billion by 2031, demonstrating an 8.18% Compound Annual Growth Rate. N...
May 2026
185 pages
Alzheimers Disease Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (CSF Biomarkers, Amyloid Beta, Tau Protein, Genetic Biomarkers, Apolipoprotein E, Blood Biomarkers, Others), By Detection Technique (Molecular Diagnostics, Immunoassays), By End user (Hospitals & Clinics, Diagnostic Laboratories, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Alzheimer’s Disease Biomarkers Market is projected to expand from USD 0.91 Billion in 2025 to USD 1.43 Billion by 2031, reflecting a compound annual growth rate of 7.82%. These biomarkers f...
May 2026
185 pages
Immunoassay for Neurological Biomarkers Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Services), By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis), By Application, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
Immunoassay For Neurological Biomarkers Market The global immunoassay for neurological biomarkers market size was estimated at USD 1.08 billion in 2025 and is projected to reach USD 2.12 billion by 20...
May 2026
150 pages
Cancer Biomarkers Market by Profiling Technology (Omics, Imaging), Cancer (Lung, Breast, Leukemia, Melanoma), Product (Instruments, Consumables), Application (Diagnostics, R&D), End User (Diagnostic Laboratories), And Region - Global Forecast to 2032
US$ 7,150.00
... factors expected to restrain the market. “The lung cancer segment is expected to register the highest CAGR’ The cancer biomarkers market on the basis of cancer type is classified into breast ...
May 2026
468 pages
Cancer Biomarkers Market Size, Share & Trends Analysis Report By Type (Breast Cancer, Prostate Cancer, Colorectal Cancer , Cervical Cancer ), By Biomolecule (Genetic Biomarkers, Epigenetic Biomarkers), By Application, By Technology, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
... cancer biomarkers Genetic biomarkers, being the highest used and easily detectable held the majority share of cancer biomarker market by biomolecule in 2016 However, epigenetic biomarkers ... 16.7% Some of the major companies in the cancer biomarkers market are Abbott Laboratories; F.Hoffmann-La Roche Ltd.; ...
May 2026
150 pages
Biomarkers Market - 2026-2033
US$ 3,400.00
Biomarkers Marketis is growing with a CAGR of 11.90% during the forecast period 2026-2035. The Biomarkers Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned r...
April 2026
36 pages
Exosome Diagnostics and Therapeutics Market - 2026-2033
US$ 3,400.00
Exosome Diagnostics and Therapeutics Market reached USD 1.35 billion in 2025 and is expected to reach USD 7.50 billion by 2033, growing with a CAGR of 22.60% during the forecast period 2026-2033. The...
April 2026
62 pages
Custom Antibody Services Market - 2026-2033
US$ 3,400.00
Custom Antibody Services Market reached US$ 679.0 million in 2025 and is expected to reach US$ 1,451.0 million by 2033, growing with a CAGR of 9.90% during the forecast period 2026-2033. The Custom An...
April 2026
50 pages
Biomarker Technologies Market Report by Test Type (Solid Biopsy, Liquid Biopsy), Indication (Cancer, Infectious Diseases, Autoimmune Disorders, Cardiovascular Disorders, and Others), Product (Consumables, Assay, Reagent, Instruments), Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Immunoassay, and Others), Application (Drug Discovery, Clinical Diagnostics, Personalized Medicine), and Region 2026-2034
US$ 2,999.00
The global biomarker technologies market size reached USD 50.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 129.4 Billion by 2034, exhibiting a growth rate (CAGR) of 1...
April 2026
141 pages
Global Cardiac Biomarkers Market - 2026-2033
US$ 3,400.00
Global Cardiac Biomarkers Market reached US$ 25.20 billion in 2025 and is expected to reach US$ 73.28 billion by 2033, growing with a CAGR of 13.22% during the forecast period 2026-2033. The Global Ca...
March 2026
51 pages
Neuroscience Antibodies and Assays Market - 2026-2033
US$ 3,400.00
Neuroscience Antibodies and Assays Market reached US$ 5.19 billion in 2025 and is expected to reach US$ 11.35 billion by 2033, growing with a CAGR of 5.39% during the forecast period 2026-2033. The Ne...
March 2026
60 pages
Cardiac Biomarkers Market Size, Share & Trends Analysis Report By Type (Troponin, Creatine kinase - MB (CK-MB), Myoglobin, BNP and NT-proBNP), By Application (Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure), By End Use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global cardiac biomarkers market size was estimated at USD 20.81 billion in 2025 and is expected to reach USD 49.31 billion by 2033, growing at a CAGR of 11.5% from 2026 to 2033. The market is dri...
February 2026
130 pages
Central Nervous System (CNS) Biomarkers: Technologies and Global Markets
US$ 4,650.00
... report provides a comprehensive analysis of CNS biomarkers on a global basis. Its aim is to provide a range of information, from detailed product analyses within disease ... sub segments to overall industry trends, in order to quantify and qualify the market for products and services in the CNS biomarkers ...
February 2026
172 pages
Genomic Biomarker Market - 2024-2031
US$ 3,400.00
Genomic Biomarker Marketis is growing with a CAGR of 15.00% during the forecast period 2026-2035. The Genomic Biomarker Market emerges as a key focus in DataM Intelligence latest in-depth analysis, wh...
January 2026
43 pages
Renal Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Functional Biomarker, Serum Creatinine, Serum Cystatin C, Urine Albumin, Up-regulated Protein, Neutrophil Gelatinase-Associated Lipocalin (NGAL), Kidney Injury Molecule-1, INTERLEUKIN-18, Others), By Technique (Enzyme-linked Immunosorbent Assay (ELISA), Particle-enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LC-MS)), By End user (Hospitals & Clinics, Diagnostic Laboratory, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Renal Biomarkers Market is projected to expand from USD 1.41 Billion in 2025 to USD 2.15 Billion by 2031, reflecting a compound annual growth rate of 7.28%. Renal biomarkers, which are meas...
January 2026
186 pages
Personalized Medicine Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Early Detection/Screening, Indication, Treatment Selection, Monitoring), By Indication (Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Personalized Medicine Biomarkers Market is projected to expand from USD 15.99 Billion in 2025 to USD 23.34 Billion by 2031, reflecting a CAGR of 6.51%. These biomarkers, which include speci...
January 2026
186 pages
Cardiac Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Troponin, CK-MB, Myoglobin, BNP and NT-proBNP, Others), By Application (Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cardiac Biomarkers Market is projected to expand from USD 18.41 Billion in 2025 to USD 29.23 Billion by 2031, registering a CAGR of 8.01%. These biomarkers, consisting of measurable enzymes...
January 2026
180 pages
PARP Inhibitor Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Kits, Assays), By Services (BRCA 1 & 2 Testing, HRD Testing, HRR Testing, Others), By Application (Breast Cancer, Ovarian Cancer, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global PARP Inhibitor Biomarkers Market is projected to expand from USD 942.14 Million in 2025 to USD 1563.61 Million by 2031, achieving a CAGR of 8.81%. These biomarkers, which encompass specific...
January 2026
180 pages
Blood-based Biomarker For Sports Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Blood-based Biomarker For Sports Medicine Market is projected to increase from USD 813.12 Million in 2025 to USD 1163.91 Million by 2031, registering a CAGR of 6.16%. These biomarkers funct...
January 2026
185 pages
Troponin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Troponin I, Troponin T, Troponin Complex, Others), By Application (Myocardial Infarction, Acute Coronary Syndrome, Congestive Heart Failure, Cardiomyopathy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Troponin Market is projected to expand from USD 2.12 Billion in 2025 to USD 3.21 Billion by 2031, registering a CAGR of 7.16%. This market is characterized by the diagnostic necessity for s...
January 2026
180 pages
Biomarker Testing Market - 2024-2031
US$ 3,400.00
The Biomarker Testing Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unpara...
January 2026
43 pages
The 2027-2032 World Outlook for Cardiac Biomarkers
US$ 1,195.00
This study covers the world outlook for cardiac biomarkers across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for cardiac biomarkers. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
The 2027-2032 World Outlook for Biomarker Systems
US$ 1,195.00
This study covers the world outlook for biomarker systems across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for biomarker systems. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
287 pages
The 2027-2032 World Outlook for Cancer Biomarkers
US$ 1,195.00
This study covers the world outlook for cancer biomarkers across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for cancer biomarkers. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...
January 2026
289 pages
